EUVIMEDEUVIMED entdecken
Crossref

Natural melanin nanoparticles modified with glycol chitosan for enhanced delivery of oxaliplatin

Güleycan Dedecengiz Varol, Miray Karamese, Seyma Uzum, Kaan Bayer, Rabia Selcen Kuru, Merve Güdül Bacanlı, Sevde Altuntas, Sakip Önder iD, Gizem Kaleli-Can iD

Journal of Biomaterials Applications · 18.06.2026

DOI: 10.1177/08853282261460756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomaterials Applications, online erschienen am 18.06.2026. Verfasst von Güleycan Dedecengiz Varol und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Yildiz Technical University, Istanbul, Turkiye. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to investigate the potential of natural melanin nanoparticles (MNPs) as carriers for oxaliplatin (OXP) delivery, with glycol chitosan (GC) surface modification to improve dispersion behavior and drug interaction. The isolated MNPs were spherical with an average diameter of 148 ± 28 nm, which increased to 261 ± 39 nm after GC coating. The particle size decreased to 148 ± 59 nm after OXP loading. Physicochemical characterization confirmed surface modification and drug association. The OXP-loaded GC-MNP formulation showed a loading efficiency of 67.8 ± 4.6% and a biphasic release profile, with an initial rapid release followed by complete drug release within 24 h. Release kinetic analysis showed the best fit with the first-order model, indicating concentration-dependent release behavior. Biological studies demonstrated time-dependent responses in MCF-7 cells. All tested formulations showed low cytotoxicity at 6 h. However, OXP-loaded GC-MNP exhibited higher cytotoxicity than free OXP under selected conditions. Furthermore, concentration-dependent genotoxic effects were observed in comet assay experiments. These findings suggest that GC-coated melanin nanoparticles may serve as a promising carrier platform for short-term modulation of OXP delivery in breast cancer applications.

Schlagwörter

Stichwörter der Autor:innen

breast cancerdrug deliveryglycol chitosannatural melanin nanoparticlesoxaliplatin

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Yildiz Technical University, Istanbul, Turkiye.
  • Department of Tissue Engineering, Institution of Health Sciences, University of Health Sciences Turkey, Istanbul, Turkiye.
  • Experimental Medicine Research and Application Center, Validebag Research Park, University of Health Sciences Turkey, Istanbul, Turkiye.
  • Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Uskudar University, Istanbul, Turkiye.
  • Department of Pharmaceutical Toxicology, Gülhane Faculty of Pharmacy, University of Health Sciences Turkey, Ankara, Turkiye.
  • Department of Biomedical Engineering, İzmir Democracy University, İzmir, Turkiye.

ORCID-Profile: Sakip Önder, Gizem Kaleli-Can

Förderung

  • Türkiye Bilimsel ve Teknolojik Araştırma Kurumu

Zitieren

APA

Dedecengiz Varol, G., Karamese, M., Uzum, S., Bayer, K., Selcen Kuru, R., Güdül Bacanlı, M., Altuntas, S., Önder, S., & Kaleli-Can, G. (2026). Natural melanin nanoparticles modified with glycol chitosan for enhanced delivery of oxaliplatin. Journal of Biomaterials Applications. https://doi.org/10.1177/08853282261460756

Vancouver

Dedecengiz Varol G, Karamese M, Uzum S, Bayer K, Selcen Kuru R, Güdül Bacanlı M, et al. Natural melanin nanoparticles modified with glycol chitosan for enhanced delivery of oxaliplatin. Journal of Biomaterials Applications. 2026. doi:10.1177/08853282261460756

BibTeX
@article{DedecengizVarol2026,
  author = {Dedecengiz Varol, Güleycan and Karamese, Miray and Uzum, Seyma and Bayer, Kaan and Selcen Kuru, Rabia and Güdül Bacanlı, Merve and Altuntas, Sevde and Önder, Sakip and Kaleli-Can, Gizem},
  title = {Natural melanin nanoparticles modified with glycol chitosan for enhanced delivery of oxaliplatin},
  journal = {Journal of Biomaterials Applications},
  year = {2026},
  doi = {10.1177/08853282261460756}
}
Kostenlos starten →